Dr Gillian Horne

  • Clinical Senior Research Fellow (Paul O'Gorman Leukaemia Research Centre)

email: Gillian.Horne@glasgow.ac.uk
pronouns: She/her/hers

RI Cancer Sciences, Paul o Gorman Leukaemia Research

Import to contacts

ORCID iDhttps://orcid.org/0000-0001-9741-7352

Research interests

Research groups

Publications

List by: Type | Date

Jump to: 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012
Number of items: 27.

2025

Estcourt, L. J. et al. (2025) Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial. Lancet Haematology, 12(1), e14-e22. (doi: 10.1016/S2352-3026(24)00317-X) (PMID:39642900)

2024

Innes, A. I. et al. (2024) Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy. Leukemia, 38(11), pp. 2443-2455. (doi: 10.1038/s41375-024-02411-7) (PMID:39300220) (PMCID:PMC11518997)

2023

Leak, Steven, Horne, Gillian ORCID logoORCID: https://orcid.org/0000-0001-9741-7352 and Copland, Mhairi ORCID logoORCID: https://orcid.org/0000-0002-7655-016X (2023) Targeting BCR-ABL1-positive leukaemias, a review article. Cambridge Prisms: Precision Medicine, 1, e21. (doi: 10.1017/pcm.2023.9)

2022

Copland, M. et al. (2022) Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trial. Lancet Haematology, 9(2), e121-e132. (doi: 10.1016/S2352-3026(21)00370-7) (PMID:34906334)

2021

Darici, S. et al. (2021) Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cells. Advances in Biological Regulation, 82, 100830. (doi: 10.1016/j.jbior.2021.100830) (PMID:34555701)

Pujol-Navarro, Neret, Al Qaraghuli, Mohammed M., Kubiak-Ossowska, Karina., Alsaadi, Manal M., Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Soutar, Richard L., Paspali, Elpiniki, Ferro, Valerie A., Williams, Mark T.S. and Mulheran, Paul A. (2021) Multiple myeloma: therapeutic delivery of antibodies and aptamers. Therapeutic Delivery, 12(10), pp. 705-722. (doi: 10.4155/tde-2021-0041) (PMID:34569269)

Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Laird, Jennifer, Latif, Anne-Louise, Irvine, David, Wilson, Matthew ORCID logoORCID: https://orcid.org/0000-0001-5423-3270 and Douglas, Kenneth (2021) The implications of CAR-T cell therapy on apheresis services: a Scottish perspective. Journal of Clinical Apheresis, 36(3), pp. 513-515. (doi: 10.1002/jca.21871) (PMID:33378123)

2020

Kemp, Olivia, Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352 and Soutar, Richard (2020) The psychological impact of COVID19 on a shielding high-risk cohort. Scottish Medical Journal, 65(4), pp. 120-122. (doi: 10.1177/0036933020951900) (PMID:32838668)

Darici, Salihanur, Alkhaldi, Hazem, Horne, Gillian ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Jørgensen, Heather G. ORCID logoORCID: https://orcid.org/0000-0003-4663-4191, Marmiroli, Sandra and Huang, Xu ORCID logoORCID: https://orcid.org/0000-0001-6706-199X (2020) Targeting PI3K/Akt/mTOR in AML: rationale and clinical evidence. Journal of Clinical Medicine, 9(9), 2934. (doi: 10.3390/jcm9092934) (PMID:32932888) (PMCID:PMC7563273)

Horne, G. et al. (2020) A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease. Leukemia, 34(7), pp. 1775-1786. (doi: 10.1038/s41375-019-0700-9) (PMID:31925317) (PMCID:PMC7224085)

Kinstrie, R. et al. (2020) CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy. Leukemia, 34(6), pp. 1613-1625. (doi: 10.1038/s41375-019-0684-5) (PMID:31896780) (PMCID:PMC7272220)

2019

Fox, Thomas A., Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Craddock, Charles, Cook, Gordon, O'Brien, Stephen, Fox, Sonia, Hockaday, Anna, Silk, Graham and Hillmen, Peter (2019) Trial re-investment to build better research for better impact. Lancet, 394(10199), pp. 635-636. (doi: 10.1016/S0140-6736(19)31363-7) (PMID:31448733)

2017

Horne, Gillian ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Jackson, Lorna ORCID logoORCID: https://orcid.org/0000-0002-6023-9908, Helgason, Vignir ORCID logoORCID: https://orcid.org/0000-0003-1616-132X and Holyoake, Tessa L. (2017) Stem cell guardians – old and new perspectives in LSC biology. Current Drug Targets, 18(4), pp. 405-413. (doi: 10.2174/1389450117666160712092944) (PMID:27411711)

Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352 and Copland, Mhairi ORCID logoORCID: https://orcid.org/0000-0002-7655-016X (2017) Approaches for targeting self-renewal pathways in cancer stem cells: implications for hematological treatments. Expert Opinion on Drug Discovery, 12(5), pp. 465-474. (doi: 10.1080/17460441.2017.1303477) (PMID:28277836)

2016

Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Morrison, Heather, Campbell, Victoria, Kinstrie, Ross, Cassels, Jennifer, Hair, Alan, Vetrie, David ORCID logoORCID: https://orcid.org/0000-0003-2075-4662, Wheadon, Helen ORCID logoORCID: https://orcid.org/0000-0001-9902-3170, Holyoake, Tessa L. and Copland, Mhairi ORCID logoORCID: https://orcid.org/0000-0002-7655-016X (2016) Notch Pathway Activation Targets Leukemic Stem Cells in Chronic-Phase Chronic Myeloid Leukemia (CP-CML). American Society of Hematology 58th Annual Meeting, San Diego, CA, USA, 3-6 Dec 2016.

2015

Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Chevassut, Timothy J.T., Fidler, Katy and Wynne, Catherine (2015) Haemolytic anaemia: don't leave it out in the cold. Archives of Disease in Childhood: Education and Practice, 100(6), pp. 323-330. (doi: 10.1136/archdischild-2014-308132) (PMID:26239653)

Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Kinstrie, Ross and Copland, Mhairi ORCID logoORCID: https://orcid.org/0000-0002-7655-016X (2015) Novel drug therapies in myelois leukemia: a patent review. Pharmaceutical Patent Analyst, 4(3), pp. 187-205. (doi: 10.4155/ppa.15.3) (PMID:26030080)

Igbineweka, Norris E., Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Jackson, Mark B. and Chevassut, Timothy J. (2015) Low oxygen affinity variant haemoglobin in an elderly woman presenting with low oxygen saturation. Acute Medicine, 14(2), pp. 72-6. (PMID:26305085)

2014

Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Stewart, Helen J.S., Dickson, Jacqueline, Knapp, Stefan, Ramsahoye, Bernard and Chevassut, Timothy (2014) Nanog requires BRD4 to maintain murine embryonic stem cell pluripotency and is suppressed by bromodomain inhibitor JQ1 together with Lefty1. Stem Cells and Development, 24(7), pp. 879-891. (doi: 10.1089/scd.2014.0302) (PMID:25393219) (PMCID:PMC4367495)

Bisling, Kathrin E., Brewin, John N., McGovern, Andrew P., Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Rider, Tom, Stewart, Helen J., Ramsahoye, Bernard H. and Chevassut, Timothy J. (2014) DNMT3A mutations at R882 hotspot are only found in major clones of acute myeloid leukemia. Leukemia and Lymphoma, 55(3), pp. 711-714. (doi: 10.3109/10428194.2013.811580) (PMID:23741974)

2013

Stewart, Helen Jayne Susan, Horne, Gillian Abigail ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Bastow, Sarah and Chevassut, Timothy James Telfer (2013) BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1. Cancer Medicine, 2(6), pp. 826-835. (doi: 10.1002/cam4.146) (PMID:24403256) (PMCID:PMC3892387)

Brewin, John, Horne, Gillian ORCID logoORCID: https://orcid.org/0000-0001-9741-7352 and Chevassut, Timothy (2013) Genomic landscapes and clonality of de novo AML. New England Journal of Medicine, 369(15), pp. 1472-1473. (doi: 10.1056/NEJMc1308782) (PMID:24106950) (PMCID:PMC4374653)

Brewin, John N., Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Bisling, Kathrin E., Stewart, Helen J. and Chevassut, Timothy J. (2013) Rapid detection of DNMT3A R882 codon mutations allows early identification of poor risk patients with acute myeloid leukemia. Leukemia and Lymphoma, 54(6), pp. 1336-1339. (doi: 10.3109/10428194.2012.736986) (PMID:23035745)

Glew, Simon, Horne, Gillian ORCID logoORCID: https://orcid.org/0000-0001-9741-7352 and Ryan, Paul (2013) Tips for GP trainees working in haematology. British Journal of General Practice, 63(611), pp. 333-334. (doi: 10.3399/bjgp13X668429) (PMID:23735406) (PMCID:PMC3662452)

2012

Horne, G.A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352 and Chevassut, T. (2012) Pregnancy in Shwachman-Diamond syndrome: a novel genetic mutation with minimal consequence. BMJ Case Reports, 2012(oct31), bcr2012007. (doi: 10.1136/bcr-2012-007305) (PMID:23125299) (PMCID:PMC4543924)

Horne, Gillian ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Brewin, John and Chevassut, Timothy (2012) Genetic profiling in acute myeloid leukemia. New England Journal of Medicine, 366(24), pp. 2321-2322. (doi: 10.1056/NEJMc1204662) (PMID:22694006)

Jones, C.I., Zabolotskaya, M.V., King, A.J., Stewart, H.J.S., Horne, G.A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Chevassut, T.J. and Newbury, S.F. (2012) Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma. British Journal of Cancer, 107(12), pp. 1987-1996. (doi: 10.1038/bjc.2012.525) (PMID:23169280) (PMCID:PMC3516695)

This list was generated on Sun Jun 15 21:12:48 2025 BST.
Jump to: Articles | Conference or Workshop Item
Number of items: 27.

Articles

Estcourt, L. J. et al. (2025) Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial. Lancet Haematology, 12(1), e14-e22. (doi: 10.1016/S2352-3026(24)00317-X) (PMID:39642900)

Innes, A. I. et al. (2024) Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy. Leukemia, 38(11), pp. 2443-2455. (doi: 10.1038/s41375-024-02411-7) (PMID:39300220) (PMCID:PMC11518997)

Leak, Steven, Horne, Gillian ORCID logoORCID: https://orcid.org/0000-0001-9741-7352 and Copland, Mhairi ORCID logoORCID: https://orcid.org/0000-0002-7655-016X (2023) Targeting BCR-ABL1-positive leukaemias, a review article. Cambridge Prisms: Precision Medicine, 1, e21. (doi: 10.1017/pcm.2023.9)

Copland, M. et al. (2022) Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trial. Lancet Haematology, 9(2), e121-e132. (doi: 10.1016/S2352-3026(21)00370-7) (PMID:34906334)

Darici, S. et al. (2021) Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cells. Advances in Biological Regulation, 82, 100830. (doi: 10.1016/j.jbior.2021.100830) (PMID:34555701)

Pujol-Navarro, Neret, Al Qaraghuli, Mohammed M., Kubiak-Ossowska, Karina., Alsaadi, Manal M., Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Soutar, Richard L., Paspali, Elpiniki, Ferro, Valerie A., Williams, Mark T.S. and Mulheran, Paul A. (2021) Multiple myeloma: therapeutic delivery of antibodies and aptamers. Therapeutic Delivery, 12(10), pp. 705-722. (doi: 10.4155/tde-2021-0041) (PMID:34569269)

Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Laird, Jennifer, Latif, Anne-Louise, Irvine, David, Wilson, Matthew ORCID logoORCID: https://orcid.org/0000-0001-5423-3270 and Douglas, Kenneth (2021) The implications of CAR-T cell therapy on apheresis services: a Scottish perspective. Journal of Clinical Apheresis, 36(3), pp. 513-515. (doi: 10.1002/jca.21871) (PMID:33378123)

Kemp, Olivia, Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352 and Soutar, Richard (2020) The psychological impact of COVID19 on a shielding high-risk cohort. Scottish Medical Journal, 65(4), pp. 120-122. (doi: 10.1177/0036933020951900) (PMID:32838668)

Darici, Salihanur, Alkhaldi, Hazem, Horne, Gillian ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Jørgensen, Heather G. ORCID logoORCID: https://orcid.org/0000-0003-4663-4191, Marmiroli, Sandra and Huang, Xu ORCID logoORCID: https://orcid.org/0000-0001-6706-199X (2020) Targeting PI3K/Akt/mTOR in AML: rationale and clinical evidence. Journal of Clinical Medicine, 9(9), 2934. (doi: 10.3390/jcm9092934) (PMID:32932888) (PMCID:PMC7563273)

Horne, G. et al. (2020) A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease. Leukemia, 34(7), pp. 1775-1786. (doi: 10.1038/s41375-019-0700-9) (PMID:31925317) (PMCID:PMC7224085)

Kinstrie, R. et al. (2020) CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy. Leukemia, 34(6), pp. 1613-1625. (doi: 10.1038/s41375-019-0684-5) (PMID:31896780) (PMCID:PMC7272220)

Fox, Thomas A., Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Craddock, Charles, Cook, Gordon, O'Brien, Stephen, Fox, Sonia, Hockaday, Anna, Silk, Graham and Hillmen, Peter (2019) Trial re-investment to build better research for better impact. Lancet, 394(10199), pp. 635-636. (doi: 10.1016/S0140-6736(19)31363-7) (PMID:31448733)

Horne, Gillian ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Jackson, Lorna ORCID logoORCID: https://orcid.org/0000-0002-6023-9908, Helgason, Vignir ORCID logoORCID: https://orcid.org/0000-0003-1616-132X and Holyoake, Tessa L. (2017) Stem cell guardians – old and new perspectives in LSC biology. Current Drug Targets, 18(4), pp. 405-413. (doi: 10.2174/1389450117666160712092944) (PMID:27411711)

Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352 and Copland, Mhairi ORCID logoORCID: https://orcid.org/0000-0002-7655-016X (2017) Approaches for targeting self-renewal pathways in cancer stem cells: implications for hematological treatments. Expert Opinion on Drug Discovery, 12(5), pp. 465-474. (doi: 10.1080/17460441.2017.1303477) (PMID:28277836)

Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Chevassut, Timothy J.T., Fidler, Katy and Wynne, Catherine (2015) Haemolytic anaemia: don't leave it out in the cold. Archives of Disease in Childhood: Education and Practice, 100(6), pp. 323-330. (doi: 10.1136/archdischild-2014-308132) (PMID:26239653)

Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Kinstrie, Ross and Copland, Mhairi ORCID logoORCID: https://orcid.org/0000-0002-7655-016X (2015) Novel drug therapies in myelois leukemia: a patent review. Pharmaceutical Patent Analyst, 4(3), pp. 187-205. (doi: 10.4155/ppa.15.3) (PMID:26030080)

Igbineweka, Norris E., Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Jackson, Mark B. and Chevassut, Timothy J. (2015) Low oxygen affinity variant haemoglobin in an elderly woman presenting with low oxygen saturation. Acute Medicine, 14(2), pp. 72-6. (PMID:26305085)

Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Stewart, Helen J.S., Dickson, Jacqueline, Knapp, Stefan, Ramsahoye, Bernard and Chevassut, Timothy (2014) Nanog requires BRD4 to maintain murine embryonic stem cell pluripotency and is suppressed by bromodomain inhibitor JQ1 together with Lefty1. Stem Cells and Development, 24(7), pp. 879-891. (doi: 10.1089/scd.2014.0302) (PMID:25393219) (PMCID:PMC4367495)

Bisling, Kathrin E., Brewin, John N., McGovern, Andrew P., Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Rider, Tom, Stewart, Helen J., Ramsahoye, Bernard H. and Chevassut, Timothy J. (2014) DNMT3A mutations at R882 hotspot are only found in major clones of acute myeloid leukemia. Leukemia and Lymphoma, 55(3), pp. 711-714. (doi: 10.3109/10428194.2013.811580) (PMID:23741974)

Stewart, Helen Jayne Susan, Horne, Gillian Abigail ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Bastow, Sarah and Chevassut, Timothy James Telfer (2013) BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1. Cancer Medicine, 2(6), pp. 826-835. (doi: 10.1002/cam4.146) (PMID:24403256) (PMCID:PMC3892387)

Brewin, John, Horne, Gillian ORCID logoORCID: https://orcid.org/0000-0001-9741-7352 and Chevassut, Timothy (2013) Genomic landscapes and clonality of de novo AML. New England Journal of Medicine, 369(15), pp. 1472-1473. (doi: 10.1056/NEJMc1308782) (PMID:24106950) (PMCID:PMC4374653)

Brewin, John N., Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Bisling, Kathrin E., Stewart, Helen J. and Chevassut, Timothy J. (2013) Rapid detection of DNMT3A R882 codon mutations allows early identification of poor risk patients with acute myeloid leukemia. Leukemia and Lymphoma, 54(6), pp. 1336-1339. (doi: 10.3109/10428194.2012.736986) (PMID:23035745)

Glew, Simon, Horne, Gillian ORCID logoORCID: https://orcid.org/0000-0001-9741-7352 and Ryan, Paul (2013) Tips for GP trainees working in haematology. British Journal of General Practice, 63(611), pp. 333-334. (doi: 10.3399/bjgp13X668429) (PMID:23735406) (PMCID:PMC3662452)

Horne, G.A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352 and Chevassut, T. (2012) Pregnancy in Shwachman-Diamond syndrome: a novel genetic mutation with minimal consequence. BMJ Case Reports, 2012(oct31), bcr2012007. (doi: 10.1136/bcr-2012-007305) (PMID:23125299) (PMCID:PMC4543924)

Horne, Gillian ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Brewin, John and Chevassut, Timothy (2012) Genetic profiling in acute myeloid leukemia. New England Journal of Medicine, 366(24), pp. 2321-2322. (doi: 10.1056/NEJMc1204662) (PMID:22694006)

Jones, C.I., Zabolotskaya, M.V., King, A.J., Stewart, H.J.S., Horne, G.A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Chevassut, T.J. and Newbury, S.F. (2012) Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma. British Journal of Cancer, 107(12), pp. 1987-1996. (doi: 10.1038/bjc.2012.525) (PMID:23169280) (PMCID:PMC3516695)

Conference or Workshop Item

Horne, Gillian A. ORCID logoORCID: https://orcid.org/0000-0001-9741-7352, Morrison, Heather, Campbell, Victoria, Kinstrie, Ross, Cassels, Jennifer, Hair, Alan, Vetrie, David ORCID logoORCID: https://orcid.org/0000-0003-2075-4662, Wheadon, Helen ORCID logoORCID: https://orcid.org/0000-0001-9902-3170, Holyoake, Tessa L. and Copland, Mhairi ORCID logoORCID: https://orcid.org/0000-0002-7655-016X (2016) Notch Pathway Activation Targets Leukemic Stem Cells in Chronic-Phase Chronic Myeloid Leukemia (CP-CML). American Society of Hematology 58th Annual Meeting, San Diego, CA, USA, 3-6 Dec 2016.

This list was generated on Sun Jun 15 21:12:48 2025 BST.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Isolating a CML-like patient group in Ph+ ALL - does this alter management?
    Children's Cancer and Leukaemia Group
    2023 - 2026
     
  • Development of a novel SCLtTA/iMLL-AF9 murine model to investigate age-relevant disease biology in MLL-AF9 leukaemia
    Tenovus Scotland
    2023 - 2024
     
  • Translating the CML-like Ph+ALL population into clinical practice
    Beatson Cancer Charity
    2023 - 2026
     
  • Transcriptomic and proteomic variation of CML blast phase - a step towards novel targeted therapies
    Blood Cancer UK
    2021 - 2024
     
  • Assessing the prognostic impact of molecular mutations through next generation sequencing within mantle cell lymphoma
    NHS Greater Glasgow and Clyde Endowment Funds
    2020 - 2021
     
  • Unravelling clinical heterogeneity in Philadelphia positive ALL
    Children's Cancer and Leukaemia Group
    2019 - 2022
     
  • PROJECT S19-13 - A pre-clinical study to validate an epigenetic based therapy for precision medicine of acute myeloid leukaemia (AML)
    Tenovus Scotland
    2019 - 2021